Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:41 PM ET Form 4
Insider Selling Everpure, Inc. P

Everpure CEO Charles H. Giancarlo Sells $7.05M of Stock

Charles H. Giancarlo, CEO, sold 70,000 shares of Everpure, Inc. at $98.93 to $104.64 a share (average $100.77) in 7 transactions, worth $7.05M in total on Nov 10, 2026. Shares held after the trade: 1,369,735 (-0.0%).

Value
$7.05M
Shares
70,000
Average price
$100.77
Role
CEO
Holding change
-0.0%
Trade date
Nov 10, 2026
4:41 PM ET 8-K
Financial Results DiaMedica Therapeutics Inc. DMAC

DiaMedica Therapeutics Financial Results

DiaMedica Therapeutics reported Q3 2026 financial results and provided clinical updates on its DM199 programs. The company completed enrollment in the first two cohorts of its Phase 2 fetal growth restriction (FGR) trial and surpassed the 200-participant enrollment threshold for its ReMEDy2 Phase 2/3 acute ischemic stroke trial, with an interim analysis expected in Q1 2027.

Term
Q3 2026

“During the third quarter and recent weeks, we continued to advance DM199 across each of our clinical programs, including completing enrollment in the first two cohorts of our Phase 2 early-onset fetal growth restriction study and reaching the 200-participant enrollment threshold for the planned interim analysis of ReMEDy2.”

Rick Pauls, President and Chief Executive Officer

“Our clinical programs are providing important opportunities to evaluate the pharmacologic effects of DM199 across pregnancy-related vascular disorders and acute ischemic stroke.”

Julie Krop, MD, Chief Medical Officer
4:41 PM ET 8-K
Other 8-K Filing Mountain Crest Acquisition Corp. V MCAG

Mountain Crest Acquisition Corp. V Other 8-K Filing

Mountain Crest Acquisition Corp. V stockholders approved an amendment to the company's charter to extend the deadline for completing an initial business combination to May 16, 2027. In connection with the vote, stockholders redeemed 64,297 shares of common stock.

Term
through May 16, 2027
4:40 PM ET Form 4
Insider Buying Ecolab Inc. ECL

Ecolab Insider David MacLennan Buys $185K of Stock

David MacLennan bought 600 shares of Ecolab Inc. at $308.12 a share, worth $185K in total on Nov 12, 2026. Shares held after the trade: 26,225 (+2.3%).

Value
$185K
Shares
600
Price
$308.12
Holding change
+2.3%
Trade date
Nov 12, 2026
4:40 PM ET 8-K/A
Other 8-K Filing Sidus Space Inc. SIDU

Sidus Space Other 8-K Filing

Sidus Space announced that its financial statements for the fiscal years 2024 and 2025, along with several quarterly reports through mid-2026, should no longer be relied upon. The company intends to restate these affected financial statements in a comprehensive amendment to its 2025 Annual Report and its Q3 2026 Quarterly Report. This non-reliance determination was made by the Audit Committee and management due to identified accounting errors.

4:40 PM ET 10-Q
Financial Results CapsoVision, Inc CV

CapsoVision Q3 2026 Results: Net Loss of $7.34M, Loss Narrows

CapsoVision reported a net revenue of $10.0 million for the nine months ended September 30, 2026, a slight increase from $9.6 million in the prior year. However, the company experienced a net loss of $21.9 million during this period, driven by high research and development expenses as they pursue FDA clearances for new products like the CapsoCam Colon capsule and AI capabilities.

Key figure
Net loss $7.34M
4:40 PM ET Form 4
Insider Selling Veralto Corp VLTO

Veralto SVP, Water Quality Melissa Kapity Sells $608K of Stock

Melissa Kapity, SVP, Water Quality, sold 5,146 shares of Veralto Corp at $118.06 a share, worth $608K in total on Nov 10, 2026. Shares held after the trade: 14,715 (-25.9%).

Value
$608K
Shares
5,146
Price
$118.06
Role
SVP, Water Quality
Holding change
-25.9%
Trade date
Nov 10, 2026
4:39 PM ET Form 4
Insider Selling Magnite, Inc. MGNI

Magnite CLO Aaron Saltz Sells $276K of Stock

Aaron Saltz, CLO, sold 9,597 shares of Magnite, Inc. at $28.75 a share, worth $276K in total on Nov 9, 2026. Shares held after the trade: 214,792 (-4.3%).

Value
$276K
Shares
9,597
Price
$28.75
Role
CLO
Holding change
-4.3%
Trade date
Nov 9, 2026
4:39 PM ET 10-Q
Financial Results T1 Energy Inc. TE

T1 Energy Q3 2026 Results: Net Loss of $40.6M, Loss Narrows

T1 Energy Inc. reported a significant increase in total net sales to $624.4 million for the nine months ended September 30, 2026, driven largely by related party transactions. Despite the revenue growth, the company incurred a net loss of $104.5 million for the period, though this was an improvement from the $178.7 million loss in the prior year.

Key figure
Net loss $40.6M
4:39 PM ET 10-Q
Financial Results Blackstone Private Credit Fund BCRED

Blackstone Private Credit Fund Q3 2026 Results: Net Income $704M, Down 12.5% YoY

As of September 30, 2026, Blackstone Private Credit Fund reported total assets of $79.1 billion and total net assets of $41.1 billion, reflecting a decrease from $47.6 billion at year-end 2025. The fund's investment portfolio is primarily composed of non-controlled/non-affiliated investments valued at $71.3 billion, supported by $34.2 billion in debt.

Key figure
Net income $704M · -12.5% YoY
4:39 PM ET 8-K
Financial Results Dillard's, Inc. DDS

Dillard's Financial Results

Dillard's reported Q3 2026 net income of $130.9 million, or $8.38 per share, on total retail sales of $1.418 billion. The company achieved 1% comparable store sales growth and maintained a strong retail gross margin of 45.3%.

Term
Q3 2026

“We achieved 1% sales growth on top of last year’s 3% increase, supporting a strong 45.3% retail gross margin. As we head into the holidays, our stores and dedicated team are ready to welcome and serve our customers.”

William T. Dillard, II, Chief Executive Officer
4:39 PM ET 10-Q
Financial Results Nakamoto Inc. NAKA

Nakamoto Q3 2026 Results: Turns Profitable, Net Income $85.5M

Nakamoto Inc. reported a net income of $85.5 million for the quarter ended September 30, 2026, a significant recovery from an $86.0 million loss in the prior year, primarily driven by a $110.4 million gain on the fair value of digital assets. However, the company faces a year-to-date net loss of $286.2 million due to substantial goodwill impairment and non-operating expenses earlier in the year.

Key figure
Net income $85.5M
4:39 PM ET 10-Q
Financial Results NeuroPace Inc NPCE ▶ Call

NeuroPace Q3 2026 Results: Net Loss of $3.3M, Loss Narrows

NeuroPace reported a decrease in total assets from $105.6 million at the end of 2025 to $94.8 million as of September 30, 2026, primarily driven by a reduction in cash and short-term investments. The company maintains a significant accumulated deficit of $568.6 million and expects to lose its emerging growth company status on December 31, 2026.

Key figure
Net loss $3.3M
4:39 PM ET 8-K
Capital Raise SmartStop Self Storage REIT, Inc. SMA

SmartStop Self Storage REIT Capital Raise of $334M

SmartStop Self Storage REIT entered into forward sale agreements for an aggregate of 9,372,500 shares of common stock at an initial forward price of $35.6125 per share. The offering includes 8,150,000 initial shares and 1,222,500 shares from the full exercise of the underwriters' overallotment option. The company intends to use the net proceeds from the eventual settlement of these agreements to fund pending investments, including a Canadian joint venture and potential acquisitions.

Value
$334M
Term
through Sept 2028
4:39 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $584.20 to $598.63 a share (average $593.99) in 14 transactions, worth $5.64M in total on Nov 11, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.99
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 11, 2026
4:39 PM ET Form 4
Insider Selling Amkor Technology, Inc. AMKR

Amkor Technology CFO Megan Faust Sells $35K of Stock

Megan Faust, CFO, sold 1,000 shares of Amkor Technology, Inc. at $35.00 a share, worth $35K in total on Nov 10, 2026. Shares held after the trade: 132,105 (-0.8%).

Value
$35K
Shares
1,000
Price
$35.00
Role
CFO
Holding change
-0.8%
Trade date
Nov 10, 2026
4:38 PM ET 10-Q
Financial Results Gaxos.Ai Inc. GXAI

Gaxos.Ai Q3 2026 Results: Net Loss of $930K, Loss Narrows

GAXOS.AI INC. reported a significant revenue increase to $7.08 million for the nine months ended September 30, 2026, compared to $0.69 million in the prior year, driven by a $1.75 million gain on the sale of gaming assets. Despite the revenue growth, the company incurred a net loss attributable to common shareholders of $2.86 million due to a substantial rise in selling, general, and administrative expenses.

Key figure
Net loss $930K
4:38 PM ET Form 4
Insider Selling Magnite, Inc. MGNI

Magnite CTO David Buonasera Sells $25.3K of Stock

David Buonasera, CTO, sold 871 shares of Magnite, Inc. at $29.00 a share, worth $25.3K in total on Nov 9, 2026. Shares held after the trade: 238,578 (-0.4%).

Value
$25.3K
Shares
871
Price
$29.00
Role
CTO
Holding change
-0.4%
Trade date
Nov 9, 2026
4:38 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.57M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.52 to $592.93 a share (average $586.32) in 14 transactions, worth $5.57M in total on Nov 10, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.57M
Shares
9,500
Average price
$586.32
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 10, 2026
4:38 PM ET 10-Q
Financial Results Liquidmetal Technologies Inc LQMT

Liquidmetal Technologies Q3 2026 Results: Net Loss of $767K, Loss Widens

Liquidmetal Technologies reported a net loss of $2.37 million for the nine months ended September 30, 2026, compared to $1.64 million in the prior year period. While product revenue increased slightly to $674 thousand, the company faced higher operating expenses and a $220 thousand loss on the disposal of property and equipment.

Key figure
Net loss $767K
4:38 PM ET 10-Q
Financial Results American National Group Inc. ANG-PD

American National Group Q3 2026 Results: Net Income $945M, Up 331.5% YoY

American National Group Inc. reported net income attributable to common stockholders of $939 million for the third quarter of 2026, a significant increase from $208 million in the prior year period. Total assets remained stable at $130.5 billion, while total equity decreased to $8.1 billion primarily due to a $2.2 billion unrealized investment loss recorded in other comprehensive income.

Key figure
Net income $945M · +331.5% YoY
4:38 PM ET 10-Q
Financial Results Commonwealth Credit Partners BDC I, Inc.

Commonwealth Credit Partners BDC I Q3 2026 Results: Net Income $4.9M, Down 27.3% YoY

For the nine months ended September 30, 2026, Commonwealth Credit Partners BDC I, Inc. reported total investment income of $45.8 million and net investment income of $35.5 million, both down from the prior year period. Net asset value per share decreased to $866.13 from $895.75 at year-end 2025, primarily driven by $17.2 million in net unrealized losses on investments.

Key figure
Net income $4.9M · -27.3% YoY
4:37 PM ET Form 4
Insider Selling Magnite, Inc. MGNI

Magnite CFO Brian Gephart Sells $106K of Stock

Brian Gephart, CFO, sold 3,700 shares of Magnite, Inc. at $28.78 a share, worth $106K in total on Nov 9, 2026. Shares held after the trade: 163,310 (-2.2%).

Value
$106K
Shares
3,700
Price
$28.78
Role
CFO
Holding change
-2.2%
Trade date
Nov 9, 2026
4:37 PM ET 8-K
M&A Deal Advanced Drainage Systems, Inc. WMS

Advanced Drainage Systems M&A Deal with StormTrap Investments LLC

Advanced Drainage Systems, Inc. (ADS) has completed its acquisition of StormTrap Investments LLC from PSP Capital. The deal expands ADS's addressable market in highly engineered stormwater storage solutions and provides cross-selling opportunities within the water management industry.

Counterparty
StormTrap Investments LLC
4:37 PM ET 10-Q
Financial Results Bain Capital Private Credit

Bain Capital Private Credit Q3 2026 Results: Net Income $32.4M, Up 51.8% YoY

Bain Capital Private Credit reported total investment income of $173.3 million for the nine months ended September 30, 2026, a significant increase from $88.3 million in the prior year period. Net investment income grew to $83.1 million as the company expanded its investment portfolio to $2.4 billion at fair value, up from $1.68 billion at the end of 2025.

Key figure
Net income $32.4M · +51.8% YoY
4:36 PM ET 10-Q
Financial Results AIM ImmunoTech Inc. AIM

AIM ImmunoTech Q3 2026 Results: Net Loss of $3.14M, Loss Narrows

AIM ImmunoTech reported a net loss of $9.95 million for the nine months ended September 30, 2026, compared to $9.78 million in the prior year. The company significantly strengthened its balance sheet through equity offerings and warrant exercises, increasing total assets to $9.75 million and achieving a positive stockholders' equity of $7.08 million.

Key figure
Net loss $3.14M
4:36 PM ET 10-Q
Financial Results SES AI Corp SES

SES AI Q3 2026 Results: Net Loss of $13.4M, Loss Narrows

SES AI Corp reported total current assets of $161.6 million as of September 30, 2026, a decrease from $216.3 million at year-end 2025, primarily driven by a reduction in short-term investments. The company continues to incur losses and highlights risks related to its drone cell manufacturing, AI-based services, and the integration of UZ Energy.

Key figure
Net loss $13.4M
4:36 PM ET Form 4
Insider Buying Industrial Logistics Properties Trust ILPT

Industrial Logistics Properties Trust Insider Kevin C. Phelan Buys $12K of Stock

Kevin C. Phelan bought 2,000 shares of Industrial Logistics Properties Trust at $6.01 a share, worth $12K in total on Nov 9, 2026. Shares held after the trade: 9,500 (+26.7%).

Value
$12K
Shares
2,000
Price
$6.01
Holding change
+26.7%
Trade date
Nov 9, 2026
4:36 PM ET 10-Q
Financial Results Journey Medical Corp DERM

Journey Medical Q3 2026 Results: Net Loss of $1.31M, Loss Narrows

Journey Medical Corp reported a 16.7% increase in total revenue to $53.4 million for the nine months ended September 30, 2026, compared to the prior year. The company significantly reduced its net loss from $10.2 million to $3.9 million over the same period, driven by improved operating margins and lower research and development expenses.

Key figure
Net loss $1.31M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.